Acquisitions - Pivot Onsite Innovations Acquisition Narrative (Details) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
|
Jun. 01, 2025
USD ($)
clinic
state
|
Jun. 30, 2026
USD ($)
|
Jun. 30, 2026
USD ($)
clinic
|
Dec. 31, 2025
USD ($)
|
|
| Business Combination, Separately Recognized Transaction [Line Items] | ||||
| Number of onsite health clinics | clinic | 400 | 415 | ||
| Goodwill | $ 1,480,421 | $ 1,480,421 | $ 1,479,192 | |
| Pivot Onsite Innovations | ||||
| Business Combination, Separately Recognized Transaction [Line Items] | ||||
| Number of onsite health clinics | clinic | 240 | |||
| Number of states in which entity operates | state | 40 | |||
| Pivot Onsite Innovations Acquisition | ||||
| Business Combination, Separately Recognized Transaction [Line Items] | ||||
| Consideration transferred | $ 55,211 | |||
| Cash paid to acquire business, available borrowing capacity | 35,000 | |||
| Goodwill | $ 32,921 | |||
| Net revenues of acquiree | $ 17,000 | $ 34,200 |
| X | ||||||||||
- Definition Number of Onsite Health Clinics Operated by Entity No definition available.
|
| X | ||||||||||
- Definition Payments To Acquire Businesses, Gross, Available Borrowing Capacity No definition available.
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of acquiree's revenue since acquisition date of business combination included in consolidated statement of income. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of states the entity operates in as of the balance sheet date. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|